A tailored approach towards informing relatives at risk of inherited cardiac conditions: study protocol for a randomised controlled trial by J Peter van Tintelen, Imke Christiaans, Lieke M van den Heuvel, Yvonne M Hoedemaekers, Annette F Baas, Ellen M A Smets

Get full text

Generation and characterization of novel human induced pluripotent stem cell (iPSC) lines originating from five asymptomatic individuals carrying the PLN-R14del pathogenic variant... by Valentina Balducci, Francesco Scardigli, Magdalena Harakalova, J. Peter. van Tintelen, Pieter A. Doevendans, Kevin D. Costa, Irene C. Turnbull, Joost P. G. Sluijter, Francesca Stillitano

Get full text

<em>GMDS</em> Intragenic Deletions Associate with Congenital Heart Disease including Ebstein Anomaly by Shirley M. Lo-A-Njoe, Eline A. Verberne, Lars T. van der Veken, Eric Arends, J. Peter van Tintelen, Alex V. Postma, Mieke M. van Haelst

Get full text

Blood‐based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta‐analysis by Mark Jansen, Sila Algül, Laurens P. Bosman, Michelle Michels, Jolanda van derVelden, Rudolf A. deBoer, J. Peter vanTintelen, Folkert W. Asselbergs, Annette F. Baas

Get full text

Genetic Basis of Dilated Cardiomyopathy in Dogs and Its Potential as a Bidirectional Model by Karen R. Gaar-Humphreys, Talitha C. F. Spanjersberg, Giorgia Santarelli, Guy C. M. Grinwis, Viktor Szatmári, Bernard A. J. Roelen, Aryan Vink, J. Peter van Tintelen, Folkert W. Asselbergs, Hille Fieten, Magdalena Harakalova, Frank G. van Steenbeek

Get full text

Diagnostic value of late gadolinium enhancement at cardiovascular magnetic resonance to distinguish arrhythmogenic right ventricular cardiomyopathy from differentials by Lian Y. Rekker, Steven A. Muller, Alessio Gasperetti, Mimount Bourfiss, Marish I.F.J. Oerlemans, Maarten J. Cramer, Stefan L. Zimmerman, Dennis Dooijes, Hanke Schalkx, Pim van der Harst, Cynthia A. James, J. Peter van Tintelen, Marco Guglielmo, Birgitta K. Velthuis, Anneline S.J.M. te Riele

Get full text

Healthcare professionals’ perspective on the acceptance of gene therapy by Lian Y. Rekker, MsC, Erik Renkema, PhD, Femke Hilverda, PhD, Linda W. van Laake, MD, PhD, Pieter A. Doevendans, MD, PhD, Joost P.G. Sluijter, PhD, Pim van der Harst, MD, PhD, J. Peter van Tintelen, MD, PhD, Anneline S.J.M. te Riele, MD, PhD

Get full text

Heritability in genetic heart disease: the role of genetic background by Yigal M Pinto, Joeri A Jansweijer, Karin Y van Spaendonck-Zwarts, Michael W T Tanck, J Peter van Tintelen, Imke Christiaans, J Martijn Bos, Arthur J Moss, Heikki Swan, Annika Rydberg, Jacob Tfelt-Hansen, Iacopo Olivotto, Philippe Charron, Juan R Gimeno, Maarten P van den Berg, Jasper J van der Smagt, Alexa M C Vermeer, Sylvia G Priori, Michael J Ackerman, Arthur AM Wilde

Get full text

Identification of novel genetic risk factors of dilated cardiomyopathy: from canine to human by Julia E. Niskanen, Åsa Ohlsson, Ingrid Ljungvall, Michaela Drögemüller, Robert F. Ernst, Dennis Dooijes, Hanneke W. M. van Deutekom, J. Peter van Tintelen, Christian J. B. Snijders Blok, Marion van Vugt, Jessica van Setten, Folkert W. Asselbergs, Aleksandra Domanjko Petrič, Milla Salonen, Sruthi Hundi, Matthias Hörtenhuber, DoGA consortium, Juha Kere, W. Glen Pyle, Jonas Donner, Alex V. Postma, Tosso Leeb, Göran Andersson, Marjo K. Hytönen, Jens Häggström, Maria Wiberg, Jana Friederich, Jenny Eberhard, Magdalena Harakalova, Frank G. van Steenbeek, Gerhard Wess, Hannes Lohi

Get full text